Skip to main content
Premium Trial:

Request an Annual Quote

NCGR Licenses Sequence-Based Physical Mapping Method from KeyGene


The National Center for Genome Resources has licensed KeyGene’s Whole Genome Profiling physical mapping technology, the companies said earlier this month.

Under the non-exclusive agreement, NCGR can combine its in-house sequencing and informatics expertise with KeyGene’s WGP technology to produce higher quality genome assemblies.

KeyGene’s technology (IS 2/1/2011) produces short sequence tags of pooled BAC clones that are generated by its partner, Amplicon Express. It then assembles the BAC clones based on the sequence tags, resulting in a physical map that serves as a scaffold for assembling whole-genome sequence data.

NCGR President Greg May said in a statement that “many of our de novo genome projects will benefit from the WGP platform through guiding the order and orientation of our next-generation DNA sequencing-based scaffolds.”

“As a company with a focus on plant breeding, we are happy to collaborate with partners that can promote our technologies in their broader networks,” said Mark van Haaren, KeyGene’s vice president of business development. “We believe that this agreement will give a much larger customer base access to better genome assemblies that can be used as reference genomes and to support molecular breeding activities.”

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.